Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieties, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed. ##STR00001##

 
Web www.patentalert.com

< Therapeutic pyrazolo[3,4-b]pyridines and indazoles

> Antibodies to human eotaxin

~ 00459